Patents by Inventor Camilla Nilsberth

Camilla Nilsberth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies specific for amyloid beta protofibril
    Patent number: 8409575
    Abstract: The invention relates to a purified antibody or fragment thereof that specifically binds an A? protofibril. The invention further relates to a composition that includes such antibodies. The invention also relates to using such antibodies and compositions for treating a patient having of suspected of having Alzheimer's disease.
    Type: Grant
    Filed: August 26, 2011
    Date of Patent: April 2, 2013
    Assignee: BioArctic Neuroscience AB
    Inventors: Lars Lannfelt, Camilla Nilsberth, Anita Campbell, Jan Näslund
  • PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE
    Publication number: 20120027755
    Abstract: The invention relates to a purified antibody or fragment thereof that specifically binds an A? protofibril. The invention further relates to a composition that includes such antibodies. The invention also relates to using such antibodies and compositions for treating a patient having of suspected of having Alzheimer's disease.
    Type: Application
    Filed: August 26, 2011
    Publication date: February 2, 2012
    Inventors: Lars Lannfelt, Camilla Nilsberth, Anita Campbell, Jan Näslund
  • Arctic ? amyloid protofibril
    Patent number: 7700719
    Abstract: The present invention relates to prevention and treatment of Alzheimer's disease (AD). More specifically, the invention relates to use of a non-wild type protofibril or compound(s) with protofibril forming activity for active immunisation in the purpose of treating or preventing AD. The invention further relates to a peptide, A?-Arc, with high protofibril forming activity as well as several applications thereof, such as antibodies against said peptide for passive immunisation against AD.
    Type: Grant
    Filed: January 18, 2007
    Date of Patent: April 20, 2010
    Assignee: BioArctic Neuroscience AB
    Inventors: Lars Lannfelt, Camilla Nilsberth, Anita Campbell, Jan Näslund
  • PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE
    Publication number: 20080181902
    Abstract: The present invention relates to prevention and treatment of Alzheimer's disease (AD). More specifically, the invention relates to use of a non-wild type protofibril or compound(s) with protofibril forming activity for active immunisation in the purpose of treating or preventing AD. The invention further relates to a peptide, A?-Arc, with high protofibril forming activity as well as several applications thereof, such as antibodies against said peptide for passive immunisation against AD.
    Type: Application
    Filed: March 19, 2008
    Publication date: July 31, 2008
    Inventors: LARS LANNFELT, Camilla Nilsberth, Anita Campbell, Jan Naslund
  • Treatment of Alzheimer's disease
    Publication number: 20070248606
    Abstract: The present invention relates to prevention and treatment of Alzheimer's disease (AD). More specifically, the invention relates to use of a non-wild type protofibril or compound(s) with protofibril forming activity for active immunisation in the purpose of treating or preventing AD. The invention further relates to a peptide, A?-Arc, with high protofibril forming activity as well as several applications thereof, such as antibodies against said peptide for passive immunisation against AD.
    Type: Application
    Filed: January 18, 2007
    Publication date: October 25, 2007
    Inventors: Lars Lannfelt, Camilla Nilsberth, Anita Campbell, Jan Naslund
  • Treatment of alzheimer's disease
    Patent number: 7179463
    Abstract: A method for the treatment of Alzheimer's disease in a subject having or suspected of having Alzheimer's disease by administering to the subject a therapeutically effective amount of an antibody wherein the antibody is raised against a protofibril that contains an A?-Arc peptide.
    Type: Grant
    Filed: July 9, 2001
    Date of Patent: February 20, 2007
    Inventors: Lars Lannfelt, Camilla Nilsberth, Anita Westlind-Danielsson, Jan Näslund
  • Prevention and treatment of alzheimer's disease
    Publication number: 20020162129
    Abstract: The present invention relates to prevention and treatment of Alzheimer's disease (AD). More specifically, the invention relates to use of a non-wild type protofibril or compound(s) with protofibril forming activity for active immunization in the purpose of treating or preventing AD. The invention further relates to a peptide, A&bgr;-Arc, with high protofibril forming activity as well as several applications thereof, such as antibodies against said peptide for passive immunization against AD.
    Type: Application
    Filed: July 9, 2001
    Publication date: October 31, 2002
    Inventors: Lars Lannfelt, Camilla Nilsberth, Anita Westlind-Danielsson, Jan Naslund